Liquid biopsies are becoming essential in the lung cancer arena.
Liquid biopsies are becoming an integral part of the diagnosis and treatment planning for patients with lung cancer, explained Adijan Kuckovic, a graduate student researcher at the University of Illinois College of Medicine at Rockford.
Patients undergoing a liquid biopsy will first have their blood and platelets drawn. Then, the DNA will be isolated, and expression panels will be run to see if the person has certain cancer markers. The process is currently one of the most highly specific technologies available in the lung cancer space.